60 results
Page 2 of 3
6-K
EX-99.1
v792 wdo47
8 Dec 20
Gamida Cell Presents Updated, Expanded Results from Phase 1 Study of Natural Killer Cell Therapy GDA-201 at ASH Annual Meeting and Exposition
3:19pm
6-K
EX-99.1
m14lc je9e9ifk9q1
10 Nov 20
Gamida Cell Reports Third Quarter 2020 Financial Results and Provides Company Update
8:23am
6-K
EX-99.1
nf0b1dilepq
5 Nov 20
Gamida Cell Announces Data to Be Presented at 62nd ASH Annual Virtual Meeting
10:36am
6-K
EX-99.3
6ug7s melwg3dljh
12 Aug 20
Report of Foreign Private Issuer
8:27am
6-K
EX-99.1
sm803i8y6rpjr
13 Jul 20
Gamida Cell Announces Appointment of David Fox to Its Board of Directors
4:10pm
6-K
EX-99.1
iu5mgumnbfpjrk
21 May 20
Gamida Cell Reports First Quarter 2020 Financial Results and Provides Company Update
8:40am
424B5
r7p5oldarh0qi byq
20 May 20
Prospectus supplement for primary offering
4:08pm
424B5
j7wg41ect 4k
18 May 20
Prospectus supplement for primary offering
4:11pm
6-K
EX-99.1
mxgznkd2reff1f ja17
25 Feb 20
Gamida Cell Reports Full Year 2019 Financial Results and Provides Company Update
5:08pm
6-K
EX-99.1
kmnhumlvskw4mo6rz
13 Jan 20
Gamida Cell Announces 2020 Goals and Provides Company Update
5:00pm
6-K
EX-99.1
vbkvhx
9 Dec 19
Gamida Cell Announces Results from Phase 1 Study of GDA-201 and New Mechanism of Action Data at ASH 2019 Annual Meeting
3:30pm
F-3
cs2uqeb2o
14 Nov 19
Shelf registration (foreign)
5:11pm
6-K
EX-99.2
4u3iybr vdi
13 Nov 19
Report of Foriegn Private Issuer
5:18pm
6-K
EX-99.3
df7bw0
13 Nov 19
Report of Foriegn Private Issuer
5:18pm
6-K
EX-99.2
heskj3p
7 Aug 19
Current report (foreign)
1:58pm
6-K
EX-99.1
nr0cuf3dsktt jc
7 Aug 19
Current report (foreign)
1:58pm
424B4
fzha03m 8k35a3
28 Jun 19
Prospectus supplement with pricing info
3:51pm
F-1/A
ph4 ii7f86
26 Jun 19
Registration statement (foreign) (amended)
12:00am